Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Asset Writedowns and Impairment (2018 - 2024)

Organogenesis Holdings has reported Asset Writedowns and Impairment over the past 6 years, most recently at $18.8 million for Q2 2024.

  • For Q2 2024, Asset Writedowns and Impairment changed N/A year-over-year to $18.8 million; the TTM value through Dec 2024 reached $18.8 million, up 15544.26%, while the annual FY2024 figure was $18.8 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q2 2024 was $18.8 million at Organogenesis Holdings, up from -$855000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $18.8 million in Q2 2024 and troughed at -$1.4 million in Q4 2020.
  • A 4-year average of $1.8 million and a median of $632000.0 in 2021 define the central range for Asset Writedowns and Impairment.
  • On a YoY basis, Asset Writedowns and Impairment climbed as much as 2937.5% in 2020 and fell as far as 613.43% in 2020.
  • Year by year, Asset Writedowns and Impairment stood at -$1.4 million in 2020, then skyrocketed by 145.93% to $632000.0 in 2021, then tumbled by 235.28% to -$855000.0 in 2022, then skyrocketed by 2303.74% to $18.8 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for ORGO at $18.8 million in Q2 2024, -$855000.0 in Q4 2022, and $733000.0 in Q3 2022.